Not a good buy right now for an impatient entry: price is pushing into near-term resistance (R1 ~34.04) with short-term momentum looking stretched.
Upside looks capped near 34.04–34.77 unless a fresh catalyst resolves the funding/liquidity narrative; downside risk is meaningful if the market re-prices liquidity concerns again.
Options positioning is broadly bullish (low put-call ratios), but options activity is very light and implied volatility is elevated—more consistent with uncertainty than a clean “risk-on” setup.
Trend/Momentum: MACD histogram is positive (0.274) and expanding, supporting a short-term upward bias.
Overbought risk: RSI(6) at ~73.3 is elevated (stretched short-term momentum), increasing odds of a pause/pullback.
Moving averages: Converging MAs suggest consolidation/transition rather than a strong, established trend.
Key levels: Pivot 32.84 as near-term “line in the sand”; resistance at R1 34.04 (very close to current price), then R2 34.77. Support at S1 31.65.
Pattern-based projection provided: ~flat next day (+0.08%), but negative bias over next week (-1.26%), implying poor immediate risk/reward chasing strength into resistance.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Open interest put-call (0.53) and volume put-call (0.2) both lean bullish (more calls than puts).
Activity/quality: Total options volume is very low (59 contracts; calls 49 vs puts 10), so the bullish read is less reliable.
Volatility/pricing: 30D IV (24.05) is below historical vol (26.57), but IV percentile is high (~80.9), suggesting IV is elevated vs its own recent history—options may be relatively expensive and the market is pricing event/uncertainty.
Positioning change: Today’s volume vs 30D average is very low (~15.9%), reinforcing that there isn’t strong conviction flow today.
Technical Summary
Sell
9
Buy
5
Positive Catalysts
Macro/news tailwind: U.S.-India trade agreement headline can support broader India-linked sentiment and cross-border growth expectations.
Technical momentum: Positive and expanding MACD can keep dips bought as long as price holds above the pivot (~32.84).
Neutral ownership signals: No notable negative hedge fund/insider trend in the provided window (both neutral).
Net income: 2.22B, +6.35% YoY (much slower than revenue growth, implying margin/funding-cost pressure).
EPS: 0.14, flat YoY (supports the idea that earnings power hasn’t scaled with revenue yet).
Takeaway: Growth is present, but profitability is not keeping pace—consistent with market concerns around funding mix and liquidity management.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so a trend summary cannot be confirmed from this dataset.
Wall Street-style pros (based on provided fundamentals/news): scale-driven revenue growth and potential macro tailwinds from U.S.-India trade easing.
Wall Street-style cons (dominant in current narrative): funding/liquidity constraints (loan vs deposit gap) and risk that profitability remains pressured until deposits catch up or funding costs normalize.
Wall Street analysts forecast HDB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HDB is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast HDB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HDB is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
